Connect with us


CBD Treatment of Anxiety Disorders



Cognitive disorders – particularly mood related ones such as depression and anxiety – have proven to be very fertile soil for the CBD revolution. We have seen one case after another, and a big batch of anecdotal evidence, to prove this point out. Today, we’re going to explore the answer to the question why.

Understanding Anxiety

It may surprise you to understand that feelings of anxiety are perfectly natural and healthy. We obsess in today’s society over anxiety as purely a defect. But in fact, it’s much more.

Evolution has armed us with a defense mechanism that has been honed over millions of years to help us respond in an accurate and timely manner to various stimuli that are probabilistically likely to emerge in our environment of evolutionary adaptation.

If you want to understand what the real problem is, then you need look no further than the vast changes we have made through culture to how the world works. We have created a daily life context that is completely detached from our longer-term environment of evolutionary adaptation.

As a result, our instincts are no longer properly suited to our daily life experiences.

In a sense, it all comes down to the hypothalamus and the amygdala – the two areas of the brain that are responsible for controlling our behavior on an instinctive basis based on sensory data streaming in through our eyes and ears and other senses.

For someone with an anxiety disorder, this instinctive response system misfires on a continual basis, constantly alerting the body of the need to be ready to fight or flee to avoid some unhappy outcome. It is an exaggeration of the fundamental misalignment that has been produced to the adaptation we have made to our world in relationship to the environment where those instincts initially evolved.

CBD and Anxiety

It may surprise you to find out that the most abundant receptors to be found in the human brain are the CB1 receptors – an intimate and integral part of the endocannabinoid system. This is also precisely why THC has such a powerful impact on the functionality of the brain (THC is a powerful agonist for the CB1 receptor).

However, research has found that CBD has an important impact on these receptors as well: it appears to effect the receptors by provoking the transportation of critical proteins that carry neurotransmitters into and out of neurons at a rapid rate.

The results? The triggering of a positive feedback loop that cycles greater and greater production of these important elements of neurochemistry.

Perhaps most importantly, this effect has been strongly seen for the neurotransmitter serotonin. This neurotransmitter plays a critical role in precisely those elements of mood regulation that are crucial to tipping the balance from disorder back to order where our anxiety system is concerned.

While we are still working to understand all of the mechanisms involved in governing this important system and helping people suffering from this difficult disorder, we do already understand certain principles that show extraordinary promise. For the most part, we can tell that CBD is responsible for several important mechanisms integral to the management of anxiety disorder, including a virtuous circle of serotonin ubiquity, the blocking of the reuptake of adenosine, and the mediation of pain signals in binding to vanilloid receptors.

That said, one may rest assured that that much more focused research is on the way.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories